Blood Plasma Thawing Device Market was valued at USD 215.0 million in 2022 and is expanded to grow at a significant CAGR of 11.4% over 2023-2029. The process of allowing frozen plasma to stand at a temperature above zero degrees Celsius is known as plasma thawing. The plasma unit is kept dry by the plasma thawing mechanism. The rise of industry players is projected to be aided by an increase in demand for manual and automated blood thawing systems from hospitals, blood banks, and transfusion medicine centers. Furthermore, a strong preference for dry plasma thawers is projected to boost demand in the coming years. Innovations in thawing methods to boost the safety and effectiveness of transfusion practices, propelling the blood thawing system market. Increased prevalence of chronic disease, which drives demand for blood and plasma products, increased launches and agreements, and technical improvements to make the thawing process easier and simpler are the primary factors driving the market growth. Sales of blood thawing systems are projected to increase in the near future as prominent manufacturers begin to incorporate cutting-edge technologies. Dry plasma thawing products are gaining preference over traditional water baths or wet plasma thawers, as they help increase the success of transfusion of adult stem cells. The industry value for blood thawing systems is expected to rise due to increased demand from major end-use sectors and prominent manufacturers' flurry of new inventions. Increased demand for automated biomedical warming and thawing devices is also helping to drive market growth. Growing demand for pharmaceutical research is further poised to increase the adoption rate for biomedical warming and thawing devices, thereby fuelling the market progression during the forecast timeframe. According to forecasts, the blood/plasma thawing device market is dominated by the blood banks segment. Major drivers driving the expansion of this end-user segment include an increase in the number of blood banks, as well as improved accessibility and availability of blood samples in blood banks.
Fastest Growing Market
On the back of advancements in regenerative medicine, advances in cryopreservation techniques, particularly for thawing red blood cells (RBC) and entire blood, have opened up new prospects for companies in the blood thawing devices market. Notably, increased public knowledge of the benefits of stem cell tissue banking has boosted demand for blood thawing devices. Factors such as high levels of consolidation, expensive device costs, and a complex regulatory framework for new product approval may limit the market's growth to some extent.
The blood/plasma thawing device market is projected to expand at a CAGR of 11.4% during the forecast period
Sartorius AG, Thermo Fisher Scientific, Inc.,, Cytiva (GE Healthcare), Cardinal Health, KW Scientific Apparatus Srl, Boekel Scientific, Barkey GmbH & Co. KG, Helmer Scientific Inc., Fremon Scientific Inc.
North-America is the fastest-growing region for blood/plasma thawing device market